- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03321578
Hospital Onset Diarrhoea Investigation (HOODINI)
National Infection Trainees Collaborative for Audit and Research (NITCAR) Service Evaluation: The Prevalence, Aetiology and Management of Hospital-onset Diarrhoea on Medical, Surgical and Elderly Care Wards in the NHS
Study Overview
Status
Conditions
Detailed Description
Latest National Health Service (NHS) England guidelines for the assessment of Clostridium difficile infection (CDI) cases recommend that acute hospitals collect data on the prevalence of hospital-onset diarrhoea in their organisations, and how it is managed, including if patients are appropriately tested for CDI.
The aims of this multi-centre service evaluation are therefore to:
- Determine the prevalence of hospital-onset diarrhoea on adult medical, surgical and care of the elderly wards in the NHS
- Investigate how hospital-onset diarrhoea is managed, including whether patients are tested for CDI according to Department of Health (DoH) England standards
- Investigate the aetiology of hospital-onset diarrhoea on adult medical, surgical and care of the elderly wards in the NHS, based on previously described causes
Data will be collected at participating centres on two days, one between 11-15/Jan/2016 and one between 6-10/Jun/2016. Hospitals will be able to choose locally which two days. On those days investigators from the local Microbiology and/or Infection Prevention teams will screen all patients on pre-identified wards, who have been admitted for ≥72 hours, for hospital-onset diarrhoea. For all patients that meet the definition of hospital-onset diarrhoea their medical notes and charts will be reviewed, to ascertain potential causes and how they have been managed.
This service evaluation should help participating hospitals to investigate hospital-onset diarrhoea in their own institutions, as well as generating a dataset that is representative of the problem across the NHS, and therefore of use to other centres.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Antrim, United Kingdom
- Antrim Area Hospital (Northern Health and Social Care Trust)
-
Barnsley, United Kingdom
- Barnsley Hospital NHS Foundation Trust
-
Blackburn, United Kingdom
- East Lancashire Hospitals NHS Trust
-
Cambridge, United Kingdom
- Cambridge University Hospitals Nhs Foundation Trust
-
Coventry, United Kingdom
- University Hospitals Coventry and Warwickshire + George Eliot Hospital NHS Trust
-
Dundonald, United Kingdom
- Ulster Hospital (South Eastern Health and Social Care Trust)
-
Edinburgh, United Kingdom
- NHS Lothian and NHS Fife
-
Glasgow, United Kingdom
- NHS Greater Glasgow and Clyde
-
Harrogate, United Kingdom
- Harrogate and District NHS Foundation Trust
-
Hull, United Kingdom
- Hull and East Yorkshire Hospitals NHS Trust
-
Leicester, United Kingdom
- University Hospitals of Leicester NHS Trust
-
London, United Kingdom
- Guy's & St Thomas' NHS Foundation Trust
-
London, United Kingdom
- The Royal Free London NHS Foundation Trust
-
Middlesborough, United Kingdom
- South Tees Hospitals NHS Foundation Trust
-
Newport, United Kingdom
- Aneurin Bevan University Health Board
-
Nottingham, United Kingdom
- Nottingham University Hospitals NHS Trust
-
Oxford, United Kingdom
- Oxford University Hospitals NHS Trust
-
Papworth, United Kingdom
- Papworth Hospital NHS Foundation Trust
-
Sheffield, United Kingdom
- Sheffield Teaching Hospitals NHS Foundation Trust
-
Torbay, United Kingdom
- Torbay and South Devon Healthcare NHS Foundation Trust
-
Wakefield, United Kingdom
- Mid Yorkshire NHS Trust
-
Winchester, United Kingdom
- Hampshire Hospitals NHS Foundation Trust
-
Wolverhampton, United Kingdom
- The Royal Wolverhampton NHS Trust
-
York, United Kingdom
- York Teaching Hospital NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Admitted to hospital for ≥72 hours at the time of data collection for the service evaluation
- Presence of hospital-onset diarrhoea (defined as ≥ 2 episodes of unformed stools (Bristol Stool Chart type 5-7) during the day before the service evaluation, with the onset of the diarrhoea being more than 48 hours after admission to hospital)
Exclusion Criteria:
- Patients admitted to the ward for ≤72hour at the time of data collection for the service evaluation
- Patients with diarrhoea since admission or in whom it developed within the first 48 hours of admission
- Patients receiving end of life care
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Point-prevalence of hospital-onset diarrhoea
Time Frame: At enrollment
|
At enrollment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
• The proportion of patients with hospital-onset diarrhoea who have been assessed for the problem by a member of the clinical team.
Time Frame: At enrollment
|
At enrollment
|
|
• The proportion of patients with hospital-onset diarrhoea that are tested for CDI (both overall and amongst those who do and do not have an alternative explanation for the diarrhoea).
Time Frame: Up to 72 hours after enrollment
|
Up to 72 hours after enrollment
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Andrew Kirby, MBBS, Leeds Teaching Hospitals NHS Trust
- Study Director: Jonathan AT Sandoe, MBChB, Leeds Teaching Hospitals NHS Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- v10.5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diarrhea
-
Aboca Spa Societa' AgricolaUnknownDiarrhea | Diarrhea, Infantile | Chronic Diarrhea | Acute Diarrhea
-
Napo Pharmaceuticals, Inc.CompletedAdult Solid Tumor | Cancer Therapy-Related Diarrhea | Chemotherapy-related Diarrhea | Prophylaxis of Diarrhea | Symptomatic Relief of Diarrhea | Targeted Therapy-related DiarrheaUnited States, Taiwan, Georgia, Serbia, Argentina
-
Hospital San BartolomeInstituto de Investigacion de las Alteraciones del Crecimiento, Desarrollo...Unknown
-
South Shore HospitalWithdrawnAntibiotic Associated Diarrhea | Clostridium Difficile Associated Diarrhea
-
Cosmo Technologies LtdBausch Health Americas, Inc.CompletedTraveler's DiarrheaGuatemala, Mexico
-
Sana'a UniversityCompleted
-
PATHUniversity of Maryland; Center for Vaccine Development - MaliCompleted
-
Johns Hopkins Bloomberg School of Public HealthNaval Medical Research CenterCompletedTravelers' DiarrheaUnited States
-
Intercell USA, Inc.CompletedTraveler's DiarrheaUnited States
-
Augusta UniversityNRS Medical College, Kolkata, West Bengal, India; School of Tropical Medicine...Terminated